Conformational sampling of membranes by Akt controls its activation and inactivation

Significance Akt is a paradigmatic lipid-activated kinase, which is frequently hyperactivated in human cancer. In the absence of PI(3,4,5)P3 or PI(3,4)P2, Akt is maintained in an inactive conformation by an inhibitory interaction between its membrane-binding PH domain and its kinase domain. Here, we describe the conformational changes associated with its binding to PI(3,4,5)P3, leading to disruption of the inhibitory PH−kinase interface, and its consequent activation by protein kinases. Intriguingly, we find that reversal of those conformational changes promotes its inactivation by protein phosphatases. The activation of Akt is thereby restricted to discrete membrane locations, and it is rapidly inactivated upon dissociation. We propose a model in which activation, substrate phosphorylation, and inactivation of Akt are tightly coupled to the membrane. The protein kinase Akt controls myriad signaling processes in cells, ranging from growth and proliferation to differentiation and metabolism. Akt is activated by a combination of binding to the lipid second messenger PI(3,4,5)P3 and its subsequent phosphorylation by phosphoinositide-dependent kinase 1 and mechanistic target of rapamycin complex 2. The relative contributions of these mechanisms to Akt activity and signaling have hitherto not been understood. Here, we show that phosphorylation and activation by membrane binding are mutually interdependent. Moreover, the converse is also true: Akt is more rapidly dephosphorylated in the absence of PIP3, an autoinhibitory process driven by the interaction of its PH and kinase domains. We present biophysical evidence for the conformational changes in Akt that accompany its activation on membranes, show that Akt is robustly autoinhibited in the absence of PIP3 irrespective of its phosphorylation, and map the autoinhibitory PH−kinase interface. Finally, we present a model for the activation and inactivation of Akt by an ordered series of membrane binding, phosphorylation, dissociation, and dephosphorylation events.

[1]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[2]  John R Engen,et al.  Conformational insight into multi-protein signaling assemblies by hydrogen-deuterium exchange mass spectrometry. , 2016, Current opinion in structural biology.

[3]  M. Andjelkovic,et al.  Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Braden D. Siempelkamp,et al.  Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1 , 2017, Proceedings of the National Academy of Sciences.

[5]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[6]  Stevan R. Hubbard,et al.  Juxtamembrane autoinhibition in receptor tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.

[7]  Dmitri I. Svergun,et al.  Automated matching of high- and low-resolution structural models , 2001 .

[8]  L. Johnson,et al.  The structural basis for control of eukaryotic protein kinases. , 2012, Annual review of biochemistry.

[9]  Maxim V. Petoukhov,et al.  New developments in the ATSAS program package for small-angle scattering data analysis , 2012, Journal of applied crystallography.

[10]  Braden D. Siempelkamp,et al.  Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas , 2017, The Journal of Biological Chemistry.

[11]  David Komander,et al.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site , 2002, The EMBO journal.

[12]  A. Newton,et al.  The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C , 2008, The EMBO journal.

[13]  N. C. Price,et al.  Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. , 2003, The Biochemical journal.

[14]  A. Newton,et al.  Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2* , 2011, The Journal of Biological Chemistry.

[15]  Dmitri I. Svergun,et al.  Uniqueness of ab initio shape determination in small-angle scattering , 2003 .

[16]  A. Newton,et al.  Spatiotemporal Dynamics of Phosphorylation in Lipid Second Messenger Signaling* , 2013, Molecular & Cellular Proteomics.

[17]  K. Kaestner,et al.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). , 2001, Science.

[18]  Spyro Mousses,et al.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer , 2007, Nature.

[19]  Dmitri I. Svergun,et al.  Electronic Reprint Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering , 2022 .

[20]  M. Cooke,et al.  Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation , 2007, Nature Immunology.

[21]  D. Braden,et al.  Conformational disruption of PI3K.DELTA. regulation by immunodeficiency mutations in PIK3CD and PIK3R1 , 2017 .

[22]  Bill X. Huang,et al.  Phosphatidylserine is a critical modulator for Akt activation , 2011, The Journal of cell biology.

[23]  J. Stockman,et al.  A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome , 2013 .

[24]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[25]  T. Leonard,et al.  A molecular ruler regulates cytoskeletal remodelling by the Rho kinases , 2015, Nature Communications.

[26]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[27]  T. Leonard,et al.  PI(3,4,5)P3 Engagement Restricts Akt Activity to Cellular Membranes. , 2017, Molecular cell.

[28]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[29]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[30]  Bill X. Huang,et al.  Interdomain Conformational Changes in Akt Activation Revealed by Chemical Cross-linking and Tandem Mass Spectrometry* , 2006, Molecular & Cellular Proteomics.

[31]  Chao Zhang,et al.  Inhibitor Hijacking of Akt Activation , 2009, Nature chemical biology.

[32]  F. McCormick,et al.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. , 1997, Science.

[33]  Michel Laguerre,et al.  3-D structure and dynamics of protein kinase B—new mechanism for the allosteric regulation of an AGC kinase , 2009, Journal of chemical biology.

[34]  J. Ferrell,et al.  Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.

[35]  Peter V. Konarev,et al.  ATSAS 2.1 – towards automated and web-supported small-angle scattering data analysis , 2007 .

[36]  A. Matsuda,et al.  Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. , 2016, Journal of medicinal chemistry.

[37]  Maria Deak,et al.  High-Resolution Structure of the Pleckstrin Homology Domain of Protein Kinase B/Akt Bound to Phosphatidylinositol (3,4,5)-Trisphosphate , 2002, Current Biology.

[38]  D. Lietha,et al.  Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses* , 2015, The Journal of Biological Chemistry.

[39]  D. Dunger,et al.  A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2 , 2004, Science.

[40]  K. Nguyen,et al.  Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors. , 2012, Journal of medicinal chemistry.

[41]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.

[42]  E. Degerman,et al.  Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. , 2002, Cellular signalling.

[43]  Roger Y Tsien,et al.  Spatio-temporal Dynamics of Protein Kinase B/Akt Signaling Revealed by a Genetically Encoded Fluorescent Reporter*♦ , 2005, Journal of Biological Chemistry.

[44]  Roger S. Armen,et al.  Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity , 2011, Proceedings of the National Academy of Sciences.

[45]  M. Falasca,et al.  Regulation and cellular functions of class II phosphoinositide 3-kinases. , 2012, The Biochemical journal.

[46]  B. Vojnovic,et al.  Intramolecular and Intermolecular Interactions of Protein Kinase B Define Its Activation In Vivo , 2007, PLoS biology.

[47]  Lewis C. Cantley,et al.  The PI3K Pathway in Human Disease , 2017, Cell.

[48]  Brian A. Hemmings,et al.  Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP , 2002, Nature Structural Biology.

[49]  J. Burke,et al.  Using Hydrogen-Deuterium Exchange Mass Spectrometry to Examine Protein-Membrane Interactions. , 2017, Methods in enzymology.

[50]  Matthew Fosbrink,et al.  Live-cell Molecular Analysis of Akt Activation Reveals Roles for Activation Loop Phosphorylation* , 2007, Journal of Biological Chemistry.

[51]  Tom D. Bunney,et al.  Phosphoinositide signalling in cancer: beyond PI3K and PTEN , 2010, Nature Reviews Cancer.

[52]  S. Schurmans,et al.  Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development , 2003, Nature Immunology.

[53]  Ruth Nussinov,et al.  The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation. , 2015, Structure.

[54]  S. Schurmans,et al.  Inositol trisphosphate 3-kinase B (InsP3KB) as a physiological modulator of myelopoiesis , 2008, Proceedings of the National Academy of Sciences.

[55]  A. Newton,et al.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. , 2005, Molecular cell.

[56]  M. Lequin,et al.  Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. , 2015, Molecular genetics and metabolism.

[57]  B. Brandhuber,et al.  An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt , 2012, Science Signaling.

[58]  S. Gabriel,et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly , 2012, Nature Genetics.

[59]  M. Laguerre,et al.  Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition , 2009, PLoS biology.

[60]  G. Mayr,et al.  Mass changes in inositol tetrakis- and pentakisphosphate isomers induced by chemotactic peptide stimulation in HL-60 cells. , 1989, The Journal of biological chemistry.

[61]  B. Brandhuber,et al.  Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition , 2010, PloS one.

[62]  T. Hunter,et al.  Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition , 2007, Oncogene.

[63]  D. Svergun,et al.  CRYSOL : a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates , 1995 .

[64]  D. Barford,et al.  Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. , 2002, Molecular cell.

[65]  Somasekar Seshagiri,et al.  Disruption of PH–kinase domain interactions leads to oncogenic activation of AKT in human cancers , 2012, Proceedings of the National Academy of Sciences.